[Hyderabad, 21 June 2025] – The Middle East and Africa (MEA) Infectious Disease Therapeutics Market is forecast to grow steadily over the next decade, reaching USD 15.3 billion by 2032, up from USD 8.4 billion in 2024, reflecting a CAGR of 7.7% during the forecast period (2024–2032). This expansion is fueled by a growing disease burden, increased healthcare investments, and enhanced...
